7101-95-3 Usage
Uses
Due to the limited information available on 3-bromo-6-nitroquinoline, its applications are not thoroughly documented. However, based on its chemical structure and properties, it can be speculated that it may have potential uses in the following areas:
Used in Chemical Research:
3-bromo-6-nitroquinoline is used as a research compound for studying the properties and reactions of quinolines and isoquinolines. Its unique structure and characteristics make it a valuable subject for scientific investigation.
Used in Pharmaceutical Industry:
3-bromo-6-nitroquinoline is used as a potential intermediate in the synthesis of pharmaceutical compounds. Its chemical properties may allow it to be incorporated into drug molecules, potentially leading to the development of new medications.
Used in Material Science:
3-bromo-6-nitroquinoline is used as a component in the development of new materials with specific properties. Its chemical structure may contribute to the creation of materials with unique characteristics, such as improved stability or reactivity.
Check Digit Verification of cas no
The CAS Registry Mumber 7101-95-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,1,0 and 1 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 7101-95:
(6*7)+(5*1)+(4*0)+(3*1)+(2*9)+(1*5)=73
73 % 10 = 3
So 7101-95-3 is a valid CAS Registry Number.
7101-95-3Relevant academic research and scientific papers
Structure activity relationship (SAR) study identifies a quinoxaline urea analog that modulates IKKβ phosphorylation for pancreatic cancer therapy
Sagar, Satish,Singh, Sarbjit,Mallareddy, Jayapal Reddy,Sonawane, Yogesh A.,Napoleon, John V.,Rana, Sandeep,Contreras, Jacob I.,Rajesh, Christabelle,Ezell, Edward L.,Kizhake, Smitha,Garrison, Jered C.,Radhakrishnan, Prakash,Natarajan, Amarnath
, (2021/06/22)
Genetic models validated Inhibitor of nuclear factor (NF) kappa B kinase beta (IKKβ) as a therapeutic target for KRAS mutation associated pancreatic cancer. Phosphorylation of the activation loop serine residues (S177, S181) in IKKβ
QUINOLINES AS FGFR KINASE MODULATORS
-
Page/Page column 147, (2013/05/21)
The invention relates to new quinoline derivative compounds of formula (I), to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. ca
QUINOLIN-, ISOQUINOLIN-, AND QUINAZOLIN-OXYALKYLAMIDES AND THEIR USE AS FUNGICIDES
-
Page 55, (2010/02/07)
Fungicidal compounds of the general formula (1) wherein one of X and Y is N or N-oxide and the other is CR or both of X and Y are N.
